Company / Operating Income per Share
Repligen Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$975.35
FY2025
5-year range
-$627.74 / $3910.36
FY2021-FY2025
Trend
+255.4%
vs FY2024
Sector context
#1 of 201
Health Care
What the data says
Operating Income per Share changed +255% YoY in FY2025, a notable deviation from the 9-year average annual change of +19644%.
Based on SEC 10-K filings.
975.35 in FY2025 with a 5-year CAGR of -5.5%. Ranks 1st among 201 companies in Health Care.
Improved from $846.14 to $975.35 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -37.1%
- 5-Year CAGR
- -5.5%
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 201This company $975.35 Sector average -$3.23
▼
+30264.3% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 255.4% year-over-year.
- Ranks #1 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Negative profit margin: -18.1%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $975.35 | +255.4% |
| FY2024 | -$627.74 | -174.2% |
| FY2023 | $846.14 | -78.4% |
| FY2022 | $3910.36 | +33.9% |
| FY2021 | $2920.67 | +125.4% |
| FY2020 | $1295.61 | +176580.9% |
| FY2019 | $0.73 | +28.3% |
| FY2018 | $0.57 | +38.1% |
| FY2017 | $0.41 | -14.6% |
| FY2016 | $0.48 | -30.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026